Related Experiment Video
Updated: Sep 4, 2025

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
Impact of COVID-19 on cancer screening: a global perspective
Leila Allahqoli1, Afrooz Mazidimoradi2, Hamid Salehiniya3
1Ministry of Health and Medical Education, Tehran.
Purpose Of Review:
Cancer screening disruption due to COVID-19 may have a significant impact on patients, healthcare practitioners, and healthcare systems. In this present review, we aim to offer a comprehensive view of the effect of the COVID-19 pandemic on cancer screening programs worldwide.
Recent Findings:
The present review comprised 33 publications. During the COVID-19 pandemic, the rates of cancer screening investigations were drastically reduced worldwide. Screening rates plummeted for all types of cancer, all ages, and racial/ethnic groups. Reductions in screening percentages were higher in several underserved racial groups. Cancer screening was suspended for at least 30 days in 13 countries.
Summary:
Screenings for all types of cancer fell sharply. In the chain of cancer management, delays in any step are liable to change the outcome of the next step. Further long-term research will be needed to fully comprehend the impact of the pandemic on cancer services and patient outcomes.
Insights
The COVID-19 pandemic drastically reduced cancer screening rates globally across all demographics, with significant disparities observed in underserved racial groups. This disruption impacts cancer management and patient outcomes.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Background:
- The COVID-19 pandemic presented unprecedented challenges to global healthcare systems.
- Disruptions in routine medical services, including cancer screening, were widely reported.
- The long-term consequences of these disruptions on cancer care pathways remain a critical area of investigation.
Purpose of the Study:
- To provide a comprehensive review of the impact of the COVID-19 pandemic on worldwide cancer screening programs.
- To analyze the extent of disruption and identify affected populations and healthcare systems.
Main Methods:
- A systematic review of 33 relevant publications was conducted.
- Data were synthesized to assess changes in cancer screening rates and program suspensions.
- Analysis focused on variations across cancer types, age groups, and racial/ethnic demographics.
Main Results:
- Cancer screening rates declined sharply across all cancer types, age groups, and racial/ethnic categories globally.
- Underserved racial groups experienced disproportionately higher reductions in screening percentages.
- Cancer screening services were suspended for a minimum of 30 days in 13 countries.
Conclusions:
- The COVID-19 pandemic caused a significant global reduction in cancer screening, with potential long-term implications for patient outcomes.
- Disparities in screening reductions highlight the need for targeted interventions to address inequities in cancer care.
- Further research is essential to fully understand the pandemic's impact on cancer services and patient outcomes.
Related Concept Videos
Cancer Survival Analysis
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Preventive Healthcare Services
Cancer
Cancers Originate from Somatic Mutations in a Single Cell

